Literature DB >> 11238880

A Ras by any other name.

D Bar-Sagi1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11238880      PMCID： PMC86689          DOI： 10.1128/MCB.21.5.1441-1443.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


× No keyword cloud information.
  27 in total

1.  Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi.

Authors:  E Choy; V K Chiu; J Silletti; M Feoktistov; T Morimoto; D Michaelson; I E Ivanov; M R Philips
Journal:  Cell       Date:  1999-07-09       Impact factor: 41.582

2.  Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo.

Authors:  M Hamilton; A Wolfman
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

Review 3.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

Review 4.  Electrostatic interaction of myristoylated proteins with membranes: simple physics, complicated biology.

Authors:  D Murray; N Ben-Tal; B Honig; S McLaughlin
Journal:  Structure       Date:  1997-08-15       Impact factor: 5.006

5.  K-ras is essential for the development of the mouse embryo.

Authors:  K Koera; K Nakamura; K Nakao; J Miyoshi; K Toyoshima; T Hatta; H Otani; A Aiba; M Katsuki
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

6.  Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility.

Authors:  J K Voice; R L Klemke; A Le; J H Jackson
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

Review 7.  Function and regulation of ras.

Authors:  D R Lowy; B M Willumsen
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

8.  K-ras is an essential gene in the mouse with partial functional overlap with N-ras.

Authors:  L Johnson; D Greenbaum; K Cichowski; K Mercer; E Murphy; E Schmitt; R T Bronson; H Umanoff; W Edelmann; R Kucherlapati; T Jacks
Journal:  Genes Dev       Date:  1997-10-01       Impact factor: 11.361

9.  Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase.

Authors:  J Yan; S Roy; A Apolloni; A Lane; J F Hancock
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

10.  Fluorimetric evaluation of the affinities of isoprenylated peptides for lipid bilayers.

Authors:  J R Silvius; F l'Heureux
Journal:  Biochemistry       Date:  1994-03-15       Impact factor: 3.162
View more
  11 in total

1.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

2.  Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice.

Authors:  Nicoletta Potenza; Carmine Vecchione; Antonella Notte; Assunta De Rienzo; Annamaria Rosica; Lisa Bauer; Andrea Affuso; Mario De Felice; Tommaso Russo; Roberta Poulet; Giuseppe Cifelli; Gabriella De Vita; Giuseppe Lembo; Roberto Di Lauro
Journal:  EMBO Rep       Date:  2005-05       Impact factor: 8.807

3.  Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice.

Authors:  Marxa L Figueiredo; Timothy J Stein; Adam Jochem; Eric P Sandgren
Journal:  Liver Int       Date:  2012-01-03       Impact factor: 5.828

4.  Functional specificity of ras isoforms: so similar but so different.

Authors:  Esther Castellano; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

Review 5.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

6.  Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.

Authors:  Iris T Chan; Jeffery L Kutok; Ifor R Williams; Sarah Cohen; Lauren Kelly; Hirokazu Shigematsu; Leisa Johnson; Koichi Akashi; David A Tuveson; Tyler Jacks; D Gary Gilliland
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells.

Authors:  Juran Kato-Stankiewicz; Irina Hakimi; Gang Zhi; Jie Zhang; Ilya Serebriiskii; Lea Guo; Hironori Edamatsu; Hiroshi Koide; Sanjay Menon; Robert Eckl; Sukumar Sakamuri; Yingchun Lu; Quin-Zene Chen; Seema Agarwal; William R Baumbach; Erica A Golemis; Fuyuhiko Tamanoi; Vladimir Khazak
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

8.  K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.

Authors:  Jonathan M Ostrem; Ulf Peters; Martin L Sos; James A Wells; Kevan M Shokat
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

9.  Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Authors:  Fuqu Yu; Josephine N Harada; Helen J Brown; Hongyu Deng; Moon Jung Song; Ting-Ting Wu; Juran Kato-Stankiewicz; Christian G Nelson; Jeffrey Vieira; Fuyuhiko Tamanoi; Sumit K Chanda; Ren Sun
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

Review 10.  Metabolism addiction in pancreatic cancer.

Authors:  R Blum; Y Kloog
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.